Kutak Rock recently represented The Integris Group, Inc., the parent company of Innovize, LLC (“Innovize”), in its equity sale to Vance Street Capital. The transaction closed on November 9, 2022.

Founded as GML in 1958, the company changed its name to Innovize in 2009 and is headquartered in St. Paul, Minnesota. Innovize is an advanced medical contract manufacturer primarily focused on complex materials conversion for critical components of diagnostics, wearables and electronics-focused devices. Vance Street Capital is a middle market Los Angeles-based private equity firm with a long history of investing in medical manufacturing businesses. 

According to a press release, Vance Street has invested in Innovize to complement Excel Scientific, another company in their portfolio acquired in December 2020. This partnership “will create a medical and life sciences platform with specialized and differentiated materials expertise and complex manufacturing capabilities that serves customers across a diverse range of medical end markets.” 

Kutak Rock partner Jennifer Forbes advised The Integris Group, Inc. on the transaction. She was assisted by partner Mitch Woolery and associates Andrew Elsberry and Ben Kramer in the corporate/M&A practice group.

With more than 45 attorneys, Kutak Rock’s national M&A practice group has built a solid reputation as a leader in middle market M&A transactions. Kutak Rock’s experience includes representing buyers, sellers and private equity groups in domestic and cross-border transactions. Kutak Rock is recognized as one of only 32 law firms trusted most for M&A by The BTI M&A Outlook 2022 report, which is based on extensive client feedback.